Skip to main content

BCW Index Drops Along with Broader Stock Market

The BCW Index fell 1.9 percent for the five-day trading period ended Tuesday, mirroring a drop in the broader stock market. For the tracking period, the Dow Jones Industrial Average fell 1.5 percent, the Nasdaq declined 1.6 percent, and the Nasdaq Biotech Index dropped 2.6 percent.
 
Fourteen of the 15 companies in the Index lost value, with Qiagen and Bruker BioSciences both falling 4 percent to lead decliners for the week. Stratagene was the only firm to gain ground, closing up 2.6 percent for the week.

 
BioCommerce Week Index of Diversified
Molecular Biology Tool Companies
Company
Ticker
Current Price
(November 28, 2006)
Last
Price
(November 20, 2006)
% change
Agilent A
32.60
33.74
-3.4
Applied Biosystems ABI
36.32
36.81
-1.3
Beckman BEC
59.00
59.92
-1.5
Bio-Rad BIO
78.96
80.42
-1.8
Bruker BRKR
7.59
7.91
-4.0
GE GE
35.20
35.98
-2.2
Invitrogen IVGN
55.45
57.24
-3.1
Millipore MIL
67.95
68.64
-1.0
Molecular Devices MDCC
20.72
21.39
-3.1
PerkinElmer PKI
21.10
21.51
-1.9
Qiagen QGEN
14.24
14.83
-4.0
Sigma SIAL
75.96
76.97
-1.3
Stratagene STGN
7.40
7.21
2.6
Thermo TMO
43.69
43.84
-0.3
Waters WAT
49.43
50.74
-2.6
BCW Index Average  
40.37
41.14
-1.9
The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.